Concepedia

Edoardo Schneider

ES

Statistics

Publications

9

Citations

1K

H-Index

9

Active since

2020

Affiliations

British Heart Foundation(Current)

King's College London

International Centre for Genetic Engineering and Biotechnology

University of Trieste

Instituto di Biofisica

Edoardo Schneider is an author at British Heart Foundation specializing in molecular virology, infectious diseases, and virology.

ORCID

Publications per year

2020–2023

9

Publications

9

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

Luca Braga, Hashim Ali, Ilaria Secco et al. · Nature · 2021 · 440 citations · Full text

, , +6

Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology

Rossana Bussani, Edoardo Schneider, Lorena Zentilin et al. · EBioMedicine · 2020 · 389 citations · Full text

, , +11

SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study

Matteo Dal Ferro, Rossana Bussani, Alessia Paldino et al. · Clinical Research in Cardiology · 2021 · 42 citations · Full text

, , +14

Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors

Mario Milani, Manuela Donalisio, Rafaela Milan Bonotto et al. · Antiviral Research · 2021 · 37 citations · Full text

, , +17

Human blood vessel organoids reveal a critical role for CTGF in maintaining microvascular integrity

Sara Romeo, Ilaria Secco, Edoardo Schneider et al. · Nature Communications · 2023 · 35 citations · Full text

, , +17

1–5 of 9